SCHEMBL5609679

SCHEMBL5609679

CC(C)(C)c1cc(CCO)cc(C(C)(C)C)c1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.60
TSHR P16473 4/20 0.60
MAPK1 P28482 3/20 0.60
LMNA P02545 3/20 0.60
KMT2A Q03164 3/20 0.60
MEN1 O00255 2/20 0.60
CYP1A2 P05177 2/20 0.60
CYP3A4 P08684 2/20 0.60
BLM P54132 2/20 0.60
ATM Q13315 2/20 0.60
HIF1A Q16665 2/20 0.60
NPSR1 Q6W5P4 2/20 0.60
ALOX15 P16050 2/20 0.60
GMNN O75496 1/20 0.60
GABBR2 O75899 1/20 0.60
TP53 P04637 1/20 0.60
CYP2C9 P11712 1/20 0.60
NFKB1 P19838 1/20 0.60
CYP2C19 P33261 1/20 0.60
PMP22 Q01453 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6567286 0.89 ALDH1A1 (0.50) ALDH1A1TSHRMAPK1LMNAKMT2A
SCHEMBL284696 0.89 ALDH1A1 (0.63) ALDH1A1TSHRMAPK1LMNAKMT2A
SCHEMBL3812731 0.88 CYP1A2 (0.55) ALDH1A1TSHRMAPK1LMNAKMT2A
SCHEMBL2414760 0.88 ALDH1A1 (0.56) ALDH1A1TSHRMAPK1LMNAKMT2A
SCHEMBL6568769 0.88 ALDH1A1 (0.49) ALDH1A1TSHRMAPK1LMNAKMT2A
SCHEMBL14564005 0.87 HSPA5 (0.69) ALDH1A1TSHRMAPK1LMNAKMT2A
Methane SCHEMBL27710180 0.86 ALDH1A1 (0.55) ALDH1A1TSHRMAPK1LMNAKMT2A
SCHEMBL2413153 0.86 ALDH1A1 (0.55) ALDH1A1TSHRMAPK1LMNAKMT2A
SCHEMBL3809095 0.85 HSPA5 (0.62) ALDH1A1TSHRMAPK1LMNAKMT2A
SCHEMBL283499 0.84 ALDH1A1 (0.59) ALDH1A1TSHRMAPK1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116660543-A Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof 中国人民解放军陆军军医大学第一附属医院 2023-08-29 CN claimed
CN-115716912-B Yellowing-resistant thermoplastic resin composition and preparation method and application thereof 万华化学集团股份有限公司 2023-09-19 CN disclosed
CN-115716912-A Anti-yellowing thermoplastic resin composition and preparation method and application thereof 万华化学集团股份有限公司 2023-02-28 CN disclosed
CN-112250550-B Preparation method of antioxidant 330 兰州精细化工有限责任公司 2023-02-07 CN disclosed
CN-112250550-A Preparation method of antioxidant 330 兰州精细化工有限责任公司 2021-01-22 CN disclosed
EP-3609861-A1 LOW VOLATILE ORGANIC ANTI-OXIDATION STABILISERS FOR POLYMERIC SYSTEMS, THEIR PRODUCTION AND USE BASF SE (DE) 2020-02-19 EP disclosed
WO-2018189016-A1 LOW VOLATILE ORGANIC ANTI-OXIDATION STABILISERS FOR POLYMERIC SYSTEMS, THEIR PRODUCTION AND USE BASF SE (DE) 2018-10-18 WO disclosed
US-9394244-B2 Ethylenically unsaturated oligomers BASF SE (DE) 2016-07-19 US disclosed
US-9394244-B2 Ethylenically unsaturated oligomers BASF SE (DE) 2016-07-19 US disclosed
US-20150259280-A1 Ethylenically Unsaturated Oligomers BASF SE (DE) 2015-09-17 US disclosed
US-5914361-A IMPART HEAT STABILITY TO ORGANIC MATERIALS, INCLUDING POLYOLEFINS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1999-06-22 US disclosed
US-5889095-A OXYGEN AND HEAT RESISTANCE SUMITOMO CHEMICAL COMPANY, LTD. (JP) 1999-03-30 US disclosed
EP-0823435-A2 Phosphites, process for producing the same and their use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-02-11 EP disclosed
US-5105001-A Water solubility ETHYL CORPORATION (US) 1992-04-14 US disclosed
EP-0393239-A2 Polysiloxanes with pendant sterically hindered phenol moiety connected to the silicon atom via a carbonyloxy-containing link UNION CARBIDE CORPORATION (US) 1990-10-24 EP disclosed
EP-0390153-A2 Polymer compositions stabilized with polydialkylsiloxanes containing siloxy units having certain defined pendant sterically hindered phenol moieties UNION CARBIDE CHEMICALS AND PLASTICS COMPANY, INC. (US) 1990-10-03 EP disclosed
US-4960810-A Polymer compositions stabilized with polydialkylsiloxanes containing siloxy units having certain defined pendant sterically hindered phenol moieties UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (US) 1990-10-02 US disclosed
US-4879378-A STABILIZERS UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (US) 1989-11-07 US disclosed
US-4616086-A ANTICOAGULANTS BOEHRINGER MANNHEIM GMBH (DE) 1986-10-07 US disclosed
EP-0076996-A1 Carboxylic-acid derivatives, process for their preparation and medicines containing them Roche Diagnostics GmbH (DE) 1983-04-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150259280-A1 Ethylenically Unsaturated Oligomers VCL, INCENP, PCMT1 ALDH1A1 647/4885TSHR 4808/4885MAPK1 4577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.